Royalty Pharma
RPRX
#602
Rank
HK$308.75 B
Marketcap
HK$536.97
Share price
1.15%
Change (1 day)
78.43%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: HK$308.75 Billion

As of November 2026 Royalty Pharma has a market cap of HK$308.75 Billion. This makes Royalty Pharma the world's 602th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$308.75 B73.5%
2025HK$177.95 B52.33%
2024HK$116.82 B-11.19%
2023HK$131.53 B-3.42%
2022HK$136.20 B2.05%
2021HK$133.46 B-11.38%
2020HK$150.59 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Royalty Pharma was reported to be:

HK$304.50 Billion
by Nasdaq info icon info icon
HK$305.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
HK$1.411 T 357.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$9.445 T 2,959.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$12.28 B-96.02%๐Ÿ‡บ๐Ÿ‡ธ USA